Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2007 2
2008 2
2009 2
2015 2
2017 1
2018 5
2019 3
2020 1
2021 3
2022 4
2023 4
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital and primary care settings: a retrospective cohort study in infants in Catalonia (Spain).
Coma E, Martinez-Marcos M, Hermosilla E, Mendioroz J, Reñé A, Fina F, Perramon-Malavez A, Prats C, Cereza G, Ciruela P, Pineda V, Antón A, Ricós-Furió G, Soriano-Arandes A, Cabezas C. Coma E, et al. Among authors: mendioroz j. Arch Dis Child. 2024 Aug 16;109(9):736-741. doi: 10.1136/archdischild-2024-327153. Arch Dis Child. 2024. PMID: 38857952 Free PMC article.
Molar-Incisor Hypomineralisation and Allergic March.
Hernandez M, Mendioroz J. Hernandez M, et al. Among authors: mendioroz j. Acta Stomatol Croat. 2020 Jun;54(2):130-135. doi: 10.15644/asc54/2/2. Acta Stomatol Croat. 2020. PMID: 32801371 Free PMC article.
Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain.
Mazagatos C, Mendioroz J, Rumayor MB, Gallardo García V, Álvarez Río V, Cebollada Gracia AD, Batalla Rebollo N, Barranco Boada MI, Pérez-Martínez O, Lameiras Azevedo AS, López González-Coviella N, Castrillejo D, Fernández Ibáñez A, Giménez Duran J, Ramírez Córcoles C, Ramos Marín V, Larrauri A, Monge S; SARI Sentinel Surveillance RSV Study Group. Mazagatos C, et al. Among authors: mendioroz j. Influenza Other Respir Viruses. 2024 May;18(5):e13294. doi: 10.1111/irv.13294. Influenza Other Respir Viruses. 2024. PMID: 38716791 Free PMC article.
Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study.
Fontán-Vela M, Hernando V, Olmedo C, Coma E, Martínez M, Moreno-Perez D, Lorusso N, Vázquez Torres M, Barbas Del Buey JF, Roig-Sena J, Pastor E, Galmés Truyols A, Artigues Serra F, Sancho Martínez RM, Latasa Zamalloa P, Pérez Martínez O, Vázquez Estepa A, García Rojas AJ, Barreno Estévez AI, Sánchez-Migallón Naranjo A, Pérez Martín JJ, Peces Jiménez P, Morales Romero R, Castilla J, García Cenoz M, Huerta Huerta M, Boone ALD, Macías Ortiz MJ, Álvarez Río V, Rodríguez Recio MJ, Merino Díaz M, Berradre Sáenz B, Villegas-Moreno MT, Limia A, Diaz A, Monge S; Spanish MPOX Vaccine Effectiveness Study Group. Fontán-Vela M, et al. Clin Infect Dis. 2024 Feb 17;78(2):476-483. doi: 10.1093/cid/ciad645. Clin Infect Dis. 2024. PMID: 37864849 Free PMC article.
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.
Laniece Delaunay C, Mazagatos C, Martínez-Baz I, Túri G, Goerlitz L, Domegan L, Meijer A, Rodrigues AP, Sève N, Ilic M, Latorre-Margalef N, Lazar M, Maurel M, Melo A, Andreu Ivorra B, Casado I, Horváth JK, Buda S, Bennett C, de Lange M, Guiomar R, Enouf V, Mlinaric I, Samuelsson Hagey T, Dinu S, Rumayor M, Castilla J, Oroszi B, Dürrwald R, O'Donnell J, Hooiveld M, Gomez V, Falchi A, Kurecic Filipovic S, Dillner L, Popescu R, Bacci S, Kaczmarek M, Kissling E; VEBIS Primary Care Vaccine Effectiveness Group. Laniece Delaunay C, et al. JAMA Netw Open. 2024 Jul 1;7(7):e2419258. doi: 10.1001/jamanetworkopen.2024.19258. JAMA Netw Open. 2024. PMID: 38949812 Free PMC article.
Introduction of nirsevimab in Catalonia, Spain: description of the incidence of bronchiolitis and respiratory syncytial virus in the 2023/2024 season.
Perramon-Malavez A, de Rioja VL, Coma E, Hermosilla E, Fina F, Martínez-Marcos M, Mendioroz J, Cabezas C, Montañola-Sales C, Prats C, Soriano-Arandes A. Perramon-Malavez A, et al. Among authors: mendioroz j. Eur J Pediatr. 2024 Dec;183(12):5181-5189. doi: 10.1007/s00431-024-05779-x. Epub 2024 Sep 28. Eur J Pediatr. 2024. PMID: 39340677 Free PMC article.
Epidemiological and clinical analysis of a consecutive series of conjoined twins in Spain.
Martínez-Frías ML, Bermejo E, Mendioroz J, Rodríguez-Pinilla E, Blanco M, Egüés J, Félix V, García A, Huertas H, Nieto C, López JA, López S, Paisán L, Rosa A, Vázquez MS. Martínez-Frías ML, et al. Among authors: mendioroz j. J Pediatr Surg. 2009 Apr;44(4):811-20. doi: 10.1016/j.jpedsurg.2008.07.002. J Pediatr Surg. 2009. PMID: 19361646 Review.
SARS-CoV-2 Catalonia contact tracing program: evaluation of key performance indicators.
Herrero M, Ciruela P, Mallafré-Larrosa M, Mendoza S, Patsi-Bosch G, Martínez-Solanas È, Mendioroz J, Jané M; Epidemiological Surveillance Network of Catalonia. Herrero M, et al. Among authors: mendioroz j. BMC Public Health. 2022 Jul 20;22(1):1397. doi: 10.1186/s12889-022-13695-8. BMC Public Health. 2022. PMID: 35858841 Free PMC article.
38 results